Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib and Panitumumab in Advanced Colorectal Cancer
NCT03983993Phase 2Active, not recruiting
- Sponsor
- Emory University
- Start
- Oct 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in colorectal cancer (CRC), sponsored by Emory University. Started Oct 2019; status: active, not recruiting.
02
Drugs
niraparib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03983993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03983993.